In addition to providing 2 mechanistically distinct mouse models for MC4R-linked obesity, the study presents the first in vivo demonstration to our knowledge of MC4R-specific PC action, paving the way for the development of a targeted therapy for severely obese patients harboring MC4R mutations. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.